PROQR THERAPEUTICS EO-04 (0PQ) — Free Cash Flow Generation Index

Latest as of December 2023: 0.94x

PROQR THERAPEUTICS EO-04 (0PQ) has a Free Cash Flow Generation Index of 0.94x as of December 2023. Free cash flow of €20.18 Million represents 1% of operating cash flow (€21.55 Million). Read 0PQ liabilities breakdown for a breakdown of total debt and financial obligations.

FCF Generation Index

0.94x

Free Cash Flow / Operating CF

Free Cash Flow

€20.18 Million

EUR

Operating Cash Flow

€21.55 Million

EUR

Capital Expenditures

€1.37 Million

EUR

PROQR THERAPEUTICS EO-04 Free Cash Flow Generation Index (2023–2023)

Historical FCF Generation Index trend for PROQR THERAPEUTICS EO-04 across 1 annual periods. Explore 0PQ capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for PROQR THERAPEUTICS EO-04 (2023–2023)

Year-by-year Free Cash Flow Generation Index for PROQR THERAPEUTICS EO-04. For the full company profile including market capitalisation, see 0PQ stock market capitalisation.

Year	FCG Index	Free Cash Flow (EUR)	Operating CF	Capital Expenditures	YoY Change
2023	0.94x	€20.18 Million	€21.55 Million	€1.37 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).